Ivana Fridrichova - Search Results

Year	Number of Results
2003	1
2006	1
2007	1
2008	1
2010	1
2011	1
2013	1
2015	2
2016	1
2017	1
2018	1
2019	2
2020	2
2021	1
2022	2
2023	1
2024	0

1

MicroRNAs Contribute to Breast Cancer Invasiveness.

Fridrichova I, Zmetakova I. Fridrichova I, et al. Cells. 2019 Oct 31;8(11):1361. doi: 10.3390/cells8111361. Cells. 2019. PMID: 31683635 Free PMC article. Review.

2

Clinical Significance of microRNAs in Hematologic Malignancies and Hematopoietic Stem Cell Transplantation.

Sevcikova A, Fridrichova I, Nikolaieva N, Kalinkova L, Omelka R, Martiniakova M, Ciernikova S. Sevcikova A, et al. Among authors: fridrichova i. Cancers (Basel). 2023 May 8;15(9):2658. doi: 10.3390/cancers15092658. Cancers (Basel). 2023. PMID: 37174123 Free PMC article. Review.

3

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool.

Kalinkova L, Sevcikova A, Stevurkova V, Fridrichova I, Ciernikova S. Kalinkova L, et al. Among authors: fridrichova i. Int J Mol Sci. 2022 Dec 30;24(1):633. doi: 10.3390/ijms24010633. Int J Mol Sci. 2022. PMID: 36614080 Free PMC article. Review.

4

Epigenetic tools in potential anticancer therapy.

Sebova K, Fridrichova I. Sebova K, et al. Among authors: fridrichova i. Anticancer Drugs. 2010 Jul;21(6):565-77. doi: 10.1097/CAD.0b013e32833a4352. Anticancer Drugs. 2010. PMID: 20436342 Review.

5

Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?

Fridrichova I, Kalinkova L, Ciernikova S. Fridrichova I, et al. Int J Mol Sci. 2022 Oct 12;23(20):12141. doi: 10.3390/ijms232012141. Int J Mol Sci. 2022. PMID: 36292996 Free PMC article. Review.

6

miR-497-5p Decreased Expression Associated with High-Risk Endometrial Cancer.

Fridrichova I, Kalinkova L, Karhanek M, Smolkova B, Machalekova K, Wachsmannova L, Nikolaieva N, Kajo K. Fridrichova I, et al. Int J Mol Sci. 2020 Dec 24;22(1):127. doi: 10.3390/ijms22010127. Int J Mol Sci. 2020. PMID: 33374439 Free PMC article.

7

New aspects in molecular diagnosis of Lynch syndrome (HNPCC).

Fridrichova I. Fridrichova I. Cancer Biomark. 2006;2(1-2):37-49. doi: 10.3233/cbm-2006-21-205. Cancer Biomark. 2006. PMID: 17192058 Review.

8

Down-regulation of traditional oncomiRs in plasma of breast cancer patients.

Jurkovicova D, Smolkova B, Magyerkova M, Sestakova Z, Kajabova VH, Kulcsar L, Zmetakova I, Kalinkova L, Krivulcik T, Karaba M, Benca J, Sedlackova T, Minarik G, Cierna Z, Danihel L, Mego M, Chovanec M, Fridrichova I. Jurkovicova D, et al. Among authors: fridrichova i. Oncotarget. 2017 Aug 24;8(44):77369-77384. doi: 10.18632/oncotarget.20484. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100393 Free PMC article.

9

miR-205-5p Downregulation and ZEB1 Upregulation Characterize the Disseminated Tumor Cells in Patients with Invasive Ductal Breast Cancer.

Kalinkova L, Nikolaieva N, Smolkova B, Ciernikova S, Kajo K, Bella V, Kajabova VH, Kosnacova H, Minarik G, Fridrichova I. Kalinkova L, et al. Among authors: fridrichova i. Int J Mol Sci. 2021 Dec 22;23(1):103. doi: 10.3390/ijms23010103. Int J Mol Sci. 2021. PMID: 35008529 Free PMC article.

10

The MRE11/RAD50/NBS1 complex destabilization in Lynch-syndrome patients.

Alemayehu A, Fridrichova I. Alemayehu A, et al. Among authors: fridrichova i. Eur J Hum Genet. 2007 Sep;15(9):922-9. doi: 10.1038/sj.ejhg.5201858. Epub 2007 May 30. Eur J Hum Genet. 2007. PMID: 17534377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year